Satish Patil

Dr. Satish Patil

orcid

Research Focus & Metrics

Academic Career Length

19Years (2008-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 2008 in Indian Journal of Community Medicine
Verified
Journal Article
Open access
PDF file
SPSatish Patil
Satish Patil
RKRv Kakade
Rv Kakade
PDPm Durgawale
Pm Durgawale
SKSv Kakade
Sv Kakade
Indian Journal of Community Medicine, the official organ of the Indian Association of Preventive and Social Medicine (IAPSM), India

1 October 2017 in Indian Journal of Medical Microbiology
Verified
Journal Article
Open access
SPSatish Patil
Satish Patil
KDKailash D. Datkhile
Kailash D. Datkhile
MGM.V. Ghorpade
M.V. Ghorpade
SPSupriya Satish Patil
Supriya Satish Patil
SKSatish V. Kakade
Satish V. Kakade
Hepatitis C is global health problem affecting a significant portion of the world's population. Available data in Western Maharashtra on seroprevalence, risk factors and genotype distribution are very limited. The present study was carried out to estimate the seroprevalence, factors influencing transmission and distribution of genotype of hepatitis C virus (HCV) in a hospital-based population. This was a cross-sectional, hospital-based study. A total of 25193 serum samples were tested for HCV and HBV infection. All samples from HCV antibody-positive patients were subjected for HCV RNA detection and genotype. Chi-square, unpaired t-test, logistic regression analysis was used for statistical analysis. The seroprevalence for anti-HCV-Ab was 0.46%. Backward multivariate logistic regression analysis revealed increasing age; alcoholic, blood transfusion and dialysis were significant risk factors. Of 116 patients with HCV, 8 (6.89%) patients had HCV-HBV co-infection. The most common genotype (61.90%) was 3 followed by Genotype 1 (38.09%). In the present study, significant risk factors were a history of blood transfusion, habit of alcohol, dialysis. The prevention of HCV infection can be achieved by screening of blood and blood products and creating awareness about risk factors. Since the efficacy of current and new therapies differ by genotype, genotype study is essential.

1 January 2013 in Journal of Clinical and Diagnostic Research
Verified
Journal Article
Open access
SPSatish Patil
Satish Patil
Journal of Clinical and Diagnostic Research aims to publish findings of doctors at grass root level and post graduate students, so that all unique medical experiences are recorded in literature.

1 January 2018 in Journal of Clinical and Diagnostic Research
Verified
Journal Article
Closed access
SPSatyajeet K Pawar
Satyajeet K Pawar
SMShivaji T Mohite
Shivaji T Mohite
KDKailas D Datkhile
Kailas D Datkhile
MPMadhavi N Patil
Madhavi N Patil
PDPratik P Durgawale
Pratik P Durgawale
SPSatish Patil
Satish Patil
Journal of Clinical and Diagnostic Research aims to publish findings of doctors at grass root level and post graduate students, so that all unique medical experiences are recorded in literature.

25 March 2020 in Biomedical and Pharmacology Journal
Verified
Journal Article
Open access
KDKailas D. Datkhile
Kailas D. Datkhile
SPSatish Patil
Satish Patil
PDPratik P Durgavale
Pratik P Durgavale
MPMadhavi N. Patil
Madhavi N. Patil
NJNilam J. Jagdale
Nilam J. Jagdale
VDVinit N. Deshmukh
Vinit N. Deshmukh
Biomedical and Pharmacology Journal (BPJ) is an international, open access, peer reviewed, quarterly research journal.

10 November 2024 in Cureus
Verified
Journal Article
Open access
SHSourish Hota
Sourish Hota
SPSatish Patil
Satish Patil
PMPriyanka M Mane
Priyanka M Mane
Background Enterococcus, once benign intestinal flora, has transformed into formidable nosocomial pathogens as a result of the accelerated emergence of antibiotic resistance represents a major global health challenge, particularly within hospital settings. Enterococcus has grown more prevalent in nosocomial infections, such as urinary tract infections (UTIs), surgical site infections (SSIs) and bacteremia. The potential emergence of vancomycin-resistant Enterococcus (VRE) strains further complicates treatment choices for multi-drug resistant (MDR) infections. This study evaluated the magnitude of Enterococcus infections and their antibiotic resistance patterns in a tertiary care hospital. Material and methods A laboratory-based cross-sectional study was conducted from January 2023 to December 2023 (one year) at Krishna Hospital & Medical Research Centre, Karad, India. A total of 189 enterococcalisolates were identified from various clinical specimens, including urine, blood, pus, and other samples. These isolates were subjected to identification and antimicrobial susceptibility testing using the automated VITEK 2 (bioMérieux SA, Marcy-l'Étoile, France) system. VanA and VanB phenotypes were detected based on minimum inhibitory concentration (MIC) values using the VITEK 2 Advanced Expert System (AES) system (bioMérieux SA). Statistical analysis was done using Statistical Package for the Social Sciences (IBM SPSS Statistics for Windows, IBM Corp., Version 21.0, Armonk, NY). Results Among 189 culture-positive enterococcal isolates, the majority were obtained from urine 144 (76%), followed by blood 17 (9%), pus 12 (6%), etc. A larger proportion of these isolates were from female patients 97 (51%) aged over 60 years. A substantial proportion of these isolates originated from in-patient departments (IPD) 178 (94.2%) with intensive care units contributing the highest number 114 (60%) and out-patient departments (OPD) 11 (5.8%). The highest prevalence of infection was observed among patients with a hospital stay of 8 to 14 days (32.3%). E. faecium (57.7%) and E. faecalis (39.6%) were the predominant species with E. faecium displaying significant resistance to benzylpenicillin (96%) and nitrofurantoin (94%) whereas E. faecalis showed higher resistance to high-level gentamicin (80%). E. gallinarum (1.6%)showed complete resistance to benzylpenicillin (100%) and moderate resistance to nitrofurantoin (67%), and high-level gentamicin (67%). Conversely, E. durans showed complete resistance (100%) to both nitrofurantoin and benzylpenicillin. Among 31 VRE isolates, 16 (52%) showed the VanA and 15 (48%) showed the VanB phenotype. Conclusion Antimicrobial resistance among E. faecium and E. faecalis, particularly to benzylpenicillin, high-level gentamicin and nitrofurantoin along with the emergence of resistant species like E. durans and E. gallinarum underscores the urgent need for vigilant antimicrobial stewardship and continuous surveillance of the growing threat of MDR enterococci in clinical settings.